Evidence map›Paper›PMID 40874103›Full record

ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2025

Cervical cancer treatment and nursing considerations: Best practices for effective care.

Jodi Hyman, Christa Slatnik, Michelle Ellwood

Abstract read
In one paragraph

Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jodi HymanCancer Care Manitoba, CC33 825 Sherbrook Street, Winnipeg, MB R3A 1M5, Jhyman3@cancercare.mb.ca.
Christa SlatnikCancer Care Manitoba, 675 McDermot Ave., Winnipeg, MB R3E 0V9, cslatnik@cancercare.mb.ca.
Michelle EllwoodCancerCare Manitoba, 675 McDermot Ave., Winnipeg, MB R3E 0V9, mellwood@cancercare.mb.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past several decades, there has been excellent progress in cervical cancer prevention and early detection. However, there are still many Canadian woman who will be diagnosed with cervical cancer and will require active treatment. Advancements in personalizing treatment options based on specific staging and fertility-sparing preferences have helped decrease morbidities for some while ensuring well-needed aggressive treatment for others. Surgical procedures, for example, offer a variety of options with curative intent, particularly for those with earlier stage disease. Once the cancer has spread beyond the cervix to locally advanced stages 2 and 3, the combination of chemotherapy and radiation tends to be the mainstay treatment option. Finally, as cancer becomes more advanced into later stages 3 and 4 disease, utilizing traditional chemotherapy with the addition of novel drugs, such as monoclonal antibodies and immune check point inhibitors, offers hope where it was once lacking. This article focuses on these varying treatment options and identifies how nurses are in the prime position to help patients improve overall understanding, tolerance, and continuity of their treatment plan.

Identifiers

PMID40874103
PMCPMC12379881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.